Skip to content

Author

J. Tainer

We have 3 of 87 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Structural and kinetic basis of serine mono-ADP-ribosylation reversal by human ADP-ribosyl-acceptor hydrolase 3.

A quantitative assay to monitor ARH3-mediated reversal of protein-linked Ser-MARylation using Ser-MARylated HPF1 as a specific, defined substrate establishes a mechanistic framework for Ser-MARylation reversal and lays the groundwork for rational ARH3 inhibitor development.

Prem Shrestha, Sharon Lin, Ainsley Lederer et al. · 0 citations
Aug 2026

Dual MYC and GSPT1 Protein Degrader for MYC-Driven Hematologic Malignancies.

The data support the development of the MYC/GSPT1 degrader GT19630 as a therapeutic strategy of MYC-driven hematologic malignancies as a therapeutic strategy of therapy-resistant hematologic malignancies.

Yuki Nishida, Valeria Impedovo, Edward Ayoub et al. · 0 citations
Review Open access Sep 2026

Exploiting DNA Damage Tolerance for Precision Oncology

By integrating DDT inhibition with biomarkers like homologous recombination deficiency and tumor mutational burden, this work can drive synthetic lethality, sensitize tumors to genotoxic agents, suppress treatment-induced mutagenesis, and potentially enhance responses to immunotherapy.

Audesh Bhat, G. Lahane, R. Pandita et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.